BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 19888515)

  • 1. Heparin, heparan sulfate and heparanase in inflammatory reactions.
    Li JP; Vlodavsky I
    Thromb Haemost; 2009 Nov; 102(5):823-8. PubMed ID: 19888515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
    Casu B; Naggi A; Torri G
    Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of heparan sulfate and heparanase in neuroinflammation.
    Zhang X; Wang B; Li JP
    Matrix Biol; 2014 Apr; 35():174-81. PubMed ID: 24398134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
    Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
    J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate.
    Escobar Galvis ML; Jia J; Zhang X; Jastrebova N; Spillmann D; Gottfridsson E; van Kuppevelt TH; Zcharia E; Vlodavsky I; Lindahl U; Li JP
    Nat Chem Biol; 2007 Dec; 3(12):773-8. PubMed ID: 17952066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase involvement in physiology and disease.
    Nasser NJ
    Cell Mol Life Sci; 2008 Jun; 65(11):1706-15. PubMed ID: 18425416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.
    Ferro V
    Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
    Elli S; Guerrini M
    Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Heparan Sulfate and Heparanase in Amyloid Diseases.
    Li JP; Zhang X
    Adv Exp Med Biol; 2020; 1221():631-645. PubMed ID: 32274729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structure of heparan sulfate from Spalax. Implications of heparanase and hypoxia.
    Sandwall E; Bodevin S; Nasser NJ; Nevo E; Avivi A; Vlodavsky I; Li JP
    J Biol Chem; 2009 Feb; 284(6):3814-22. PubMed ID: 19068480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activities of heparan sulfate and its analogue heparin are dictated by biosynthesis, sequence, and conformation.
    Skidmore MA; Guimond SE; Rudd TR; Fernig DG; Turnbull JE; Yates EA
    Connect Tissue Res; 2008; 49(3):140-4. PubMed ID: 18661329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
    Han J; Hiebert LM
    Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
    Vlodavsky I; Ilan N; Naggi A; Casu B
    Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo.
    Ellyard JI; Simson L; Bezos A; Johnston K; Freeman C; Parish CR
    J Biol Chem; 2007 May; 282(20):15238-47. PubMed ID: 17384413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelet heparanase: purification, characterization and catalytic activity.
    Freeman C; Parish CR
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1341-50. PubMed ID: 9494105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
    Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
    Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives.
    Veraldi N; Zouggari N; de Agostini A
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-protein interactions.
    Capila I; Linhardt RJ
    Angew Chem Int Ed Engl; 2002 Feb; 41(3):391-412. PubMed ID: 12491369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.